AS
Anuradha Shridhar Giri
About Anuradha Shridhar Giri
Data last updated:
Anuradha Shridhar Giri is a Director at Dux Ducis Pharmaceuticals Private Limited (since 2014). The company operates in Pharma. Dux Ducis Pharmaceuticals Private Limited reported revenue of ₹4.5 Lakh (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Dec 2014 | 2014 | ₹4.5 Lakh (FY 2019) | Active |
Board colleagues of Anuradha Shridhar Giri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Prashant Rupchand Pakhidde | 07941152 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
| Vaibhav Himatrao Pande | 08279066 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
| Vaibhav Mahadeorao Giri | 06812228 | Dux Ducis Pharmaceuticals Private Limited | Director |
| Vivekanand Sudhakar Manwatkar | 07941233 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
| Yogesh Subhash Kanchalwar | 08293775 | Dux Ducis Pharmaceuticals Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anuradha Shridhar Giri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anuradha Shridhar Giri
Anuradha Shridhar Giri currently holds 1 directorship: Dux Ducis Pharmaceuticals Private Limited (Director, since 10 Dec 2014, revenue ₹4.5 Lakh (FY 2019)).
Anuradha Shridhar Giri was first appointed on 10 Dec 2014 as Director at Dux Ducis Pharmaceuticals Private Limited.
The current boards of Anuradha Shridhar Giri's companies include Prashant Rupchand Pakhidde (Dux Ducis Pharmaceuticals Private Limited), Vaibhav Himatrao Pande (Dux Ducis Pharmaceuticals Private Limited), Vaibhav Mahadeorao Giri (Dux Ducis Pharmaceuticals Private Limited), Vivekanand Sudhakar Manwatkar (Dux Ducis Pharmaceuticals Private Limited), Yogesh Subhash Kanchalwar (Dux Ducis Pharmaceuticals Private Limited).